Evolent Health, Inc.

DB:9EH Stock Report

Market Cap: €1.2b

Evolent Health Past Earnings Performance

Past criteria checks 0/6

Evolent Health has been growing earnings at an average annual rate of 35.7%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 25.1% per year.

Key information

35.7%

Earnings growth rate

42.6%

EPS growth rate

Healthcare Services Industry Growth7.9%
Revenue growth rate25.1%
Return on equity-5.9%
Net Margin-4.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Evolent Health makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:9EH Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,464-1042440
30 Jun 242,354-1062750
31 Mar 242,176-1412980
31 Dec 231,964-1423060
30 Sep 231,790-1123270
30 Jun 231,632-772980
31 Mar 231,483-402630
31 Dec 221,352-192440
30 Sep 221,218-42430
30 Jun 221,088-192290
31 Mar 22990-242150
31 Dec 21908-302080
30 Sep 21906-451990
30 Jun 21923-681990
31 Mar 21918-2611970
31 Dec 20925-3281980
30 Sep 20915-5151960
30 Jun 20895-5042070
31 Mar 20870-3342280
31 Dec 19687-3042080
30 Sep 19803-1212480
30 Jun 19733-1072470
31 Mar 19685-862410
31 Dec 18627-532310
30 Sep 18548-492200
30 Jun 18506-492060
31 Mar 18468-561990
31 Dec 17435-611950
30 Sep 17409-651910
30 Jun 17362-641800
31 Mar 17311-551630
31 Dec 16254-1601480
30 Sep 16212-1461310
30 Jun 16192-1471220
31 Mar 161462201030
31 Dec 1597330710
30 Sep 1551322380
30 Jun 1510329130
31 Mar 150-37-10
31 Dec 140-3100
30 Sep 1413-2970
31 Dec 13262160

Quality Earnings: 9EH is currently unprofitable.

Growing Profit Margin: 9EH is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 9EH is unprofitable, but has reduced losses over the past 5 years at a rate of 35.7% per year.

Accelerating Growth: Unable to compare 9EH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9EH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).

Return on Equity

High ROE: 9EH has a negative Return on Equity (-5.89%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 15:55
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Evolent Health, Inc. is covered by 23 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew GillmorBaird
David LarsenBTIG
Richard CloseCanaccord Genuity